SCHEMBL24960775

SCHEMBL24960775

Brc1cccc(-c2nc(-c3ccccc3)cc(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)n2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.53
KMT2A Q03164 6/20 0.53
MAPT P10636 5/20 0.53
ALDH1A1 P00352 5/20 0.53
HPGD P15428 5/20 0.53
KDM4E B2RXH2 2/20 0.53
LMNA P02545 2/20 0.53
SMN1; SMN2 Q16637 3/20 0.51
NPC1 O15118 2/20 0.51
TSHR P16473 2/20 0.51
RAB9A P51151 2/20 0.51
HTT P42858 1/20 0.51
GABRA1 P14867 1/20 0.49
GABRG2 P18507 1/20 0.49
GABRB3 P28472 1/20 0.49
GABRA5 P31644 1/20 0.49
GABRA3 P34903 1/20 0.49
NTSR1 P30989 1/20 0.47
MCL1 Q07820 2/20 0.46
GLA P06280 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9881175 0.93 MAPT (0.53) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL21217734 0.93 MAPT (0.57) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL29714695 0.93 MAPT (0.57) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17721066 0.93 MEN1 (0.56) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22603716 0.93 MEN1 (0.56) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL23287617 0.93 MEN1 (0.56) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL8515832 0.93 MEN1 (0.59) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22603670 0.91 MAPT (0.54) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17539932 0.91 MAPT (0.59) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18213968 0.91 MEN1 (0.62) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230023238-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230023238-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 MEN1 265/4885KMT2A 742/4885MAPT 1612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.